Copyright
©The Author(s) 2025.
World J Exp Med. Dec 20, 2025; 15(4): 109134
Published online Dec 20, 2025. doi: 10.5493/wjem.v15.i4.109134
Published online Dec 20, 2025. doi: 10.5493/wjem.v15.i4.109134
Table 1 Association between duration of hospitalization and clinical/microbiological parameters (n = 275), mean ± SD
| Parameters | Duration of hospitalization (days) | P value |
| Age (years) | Correlation coefficient (rho) = -0.06 | 0.302 |
| Age (years) | 0.682 | |
| 18-30 | 15.21 ± 15.13 | |
| 31-40 | 14.47 ± 10.44 | |
| 41-50 | 14.07 ± 9.87 | |
| 51-60 | 13.12 ± 9.46 | |
| 61-70 | 12.62 ± 8.64 | |
| 71-80 | 15.81 ± 14.51 | |
| 81-90 | 6.83 ± 1.72 | |
| > 90 | 13.00 ± 0 | |
| Gender | 0.221 | |
| Male | 12.98 ± 9.38 | |
| Female | 15.51 ± 13.76 | |
| Organism detected | 0.347 | |
| Escherichia coli | 12.05 ± 8.29 | |
| Klebsiella pneumoniae | 16.05 ± 10.89 | |
| Pseudomonas aeruginosa | 14.76 ± 11.64 | |
| Candida spp. | 14.46 ± 17.37 | |
| Enterococcus faecium | 11.44 ± 5.76 | |
| Acinetobacter baumannii | 11.27 ± 5.14 | |
| Enterobacter cloacae | 11.67 ± 4.62 | |
| Others | 24.33 ± 16.74 | |
| Enterococcus faecalis | 8.00 ± 0 | |
| Staphylococcus epidermidis | 15.00 ± 0 | |
| Localized symptoms of UTI | 0.003 | |
| Yes | 14.66 ± 11.71 | |
| No | 10.33 ± 7.90 | |
| Symptom: Increased urination | 0.002 | |
| Yes | 15.76 ± 12.28 | |
| No | 12.92 ± 10.56 | |
| Symptom: Urination urgency | < 0.001 | |
| Yes | 16.15 ± 6.92 | |
| No | 13.48 ± 11.91 | |
| Symptom: Dysuria | 0.063 | |
| Yes | 13.06 ± 10.45 | |
| No | 15.10 ± 12.23 | |
| Symptom: Pyuria | 0.018 | |
| Yes | 18.65 ± 12.18 | |
| No | 3.50 ± 11.10 | |
| Symptom: Hematuria | 0.563 | |
| Yes | 10.43 ± 4.86 | |
| No | 14.02 ± 11.37 | |
| Symptom: Flank pain | 0.174 | |
| Yes | 17.97 ± 18.20 | |
| No | 13.38 ± 9.89 | |
| Factor for asymptomatic bacteriuria: Pregnancy | 0.911 | |
| Yes | 14.00 ± 11.31 | |
| No | 13.93 ± 11.29 | |
| Factor for asymptomatic bacteriuria: Urological procedure | 0.32 | |
| Yes | 9.92 ± 4.44 | |
| No | 14.11 ± 11.45 | |
| Factor for asymptomatic bacteriuria: Post renal transplant | No patients | |
| Factor for asymptomatic bacteriuria: None | 0.004 | |
| Yes | 10.25 ± 8.86 | |
| No | 14.42 ± 11.47 | |
| SOFA score change > 1 | 0.591 | |
| Yes | 15.04 ± 13.76 | |
| No | 13.89 ± 10.48 | |
| Pathogenicity (microbiologist) (pathogenic) | 13.93 ± 11.26 | |
| Pathogenicity (treating team) | 0.487 | |
| Pathogenic | 13.98 ± 11.31 | |
| Non-pathogenic | 9.33 ± 4.04 | |
| Pathogenicity (algorithm) | < 0.001 | |
| Pathogenic | 14.68 ± 11.55 | |
| Non-pathogenic | 6.77 ± 3.06 | |
| Commensal organism | 0.459 | |
| Yes | 13.17 ± 9.45 | |
| No | 15.59 ± 14.40 | |
| Colonizer organism | 0.212 | |
| Yes | 13.89 ± 16.10 | |
| No | 13.94 ± 10.13 | |
| Contaminant organism | 0.038 | |
| Yes | 3.50 ± 0.71 | |
| No | 14.01 ± 11.27 | |
| Direct organism | 0.006 | |
| Yes | 18.08 ± 12.21 | |
| No | 13.23 ± 10.97 | |
| Type of pathogenic organism | 0.05 | |
| Pathogenic-commensal | 13.88 ± 9.65 | |
| Pathogenic-colonizer | 14.67 ± 16.95 | |
| Pathogenic-direct | 18.08 ± 12.21 | |
| Type of non-pathogenic organism | 0.093 | |
| Non-pathogenic commensal | 6.84 ± 3.22 | |
| Non-pathogenic colonizer | 7.80 ± 2.28 | |
| Non-pathogenic contaminant | 3.50 ± 0.71 | |
| Type of any organism | < 0.001 | |
| Pathogenic-commensal | 13.88 ± 9.65 | |
| Pathogenic-colonizer | 14.67 ± 16.95 | |
| Pathogenic-direct | 18.08 ± 12.21 | |
| Non-pathogenic commensal | 6.84 ± 3.22 | |
| Non-pathogenic colonizer | 7.80 ± 2.28 | |
| Non-pathogenic contaminant | 3.50 ± 0.71 | |
| Patient outcome at discharge | 0.201 | |
| Discharged | 13.43 ± 10.07 | |
| Death | 22.80 ± 28.17 | |
| DOPR | 14.29 ± 2.75 | |
| LAMA | 23.00 ± 15.64 | |
| Duration of antibiotics (days) | Correlation coefficient (rho) = -0.06 | 0.318 |
| Cost of antibiotics (Rs) | Correlation coefficient (rho) = 0.13 | 0.036 |
| Thirty-day mortality | 0.017 | |
| Yes | 27.75 ± 29.56 | |
| No | 13.52 ± 10.09 |
- Citation: Yadav B, Pilania J, Kant R, Omar BJ, Saini S, Panwar VK, Bahurupi Y, Panda PK. Stepwise model to differentiate pathogenic from non-pathogenic organisms in urinary isolates: Effectiveness, safety, and feasibility prospective study. World J Exp Med 2025; 15(4): 109134
- URL: https://www.wjgnet.com/2220-315x/full/v15/i4/109134.htm
- DOI: https://dx.doi.org/10.5493/wjem.v15.i4.109134
